How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
15
AKRO Quote, Financials, Valuation and Earnings
Last price:
$40.45
Seasonality move
:
9.58%
Day range:
$39.18 - $41.12
52-week range:
$17.86 - $58.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.30x
Volume:
1.4M
Avg. volume:
922.2K
1-year change:
60.25%
Market cap:
$3.2B
Revenue:
--
EPS (TTM):
-$3.75
Earnings Data
Next earnings date for AKRO
May 09
2025
Most recent earnings per share
-$0.99
Beat by $0.13
(Feb 28/2025)
Consensus Estimate
-$1.12
(Feb 28/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AKRO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$1.00 | -- |
| 05/09/2025 | Q1 | -- | -- | -- | -$0.99 | -- |
| 02/28/2025 | Q4 | -- | -- | -$0.99 | -$1.12 | $0.13 |
| 11/08/2024 | Q3 | -- | -- | -$1.05 | -$0.93 | -$0.12 |
| 08/09/2024 | Q2 | -- | -- | -$0.81 | -$0.89 | $0.08 |
| 05/10/2024 | Q1 | -- | -- | -$0.90 | -$0.93 | $0.03 |
| 02/29/2024 | Q4 | -- | -- | -$1.02 | -$0.83 | -$0.19 |
| 11/13/2023 | Q3 | -- | -- | -$0.71 | -$0.69 | -$0.02 |
| 08/11/2023 | Q2 | -- | -- | -$0.60 | -$0.71 | $0.11 |
| 05/15/2023 | Q1 | -- | -- | -$0.55 | -$0.64 | $0.09 |
| 03/17/2023 | Q4 | -- | -- | -$0.49 | -$0.83 | $0.34 |
| 11/04/2022 | Q3 | -- | -- | -$0.92 | -$0.73 | -$0.19 |
| 08/05/2022 | Q2 | -- | -- | -$0.77 | -$0.86 | $0.09 |
| 05/06/2022 | Q1 | -- | -- | -$0.74 | -$0.84 | $0.10 |
| 02/25/2022 | Q4 | -- | -- | -$0.93 | -$0.81 | -$0.12 |
| 11/12/2021 | Q3 | -- | -- | -$0.70 | -$0.91 | $0.21 |
| 08/13/2021 | Q2 | -- | -- | -$0.83 | -$0.71 | -$0.12 |
| 05/13/2021 | Q1 | -- | -- | -$0.43 | -$0.94 | $0.51 |
| 03/16/2021 | Q4 | -- | -- | -$0.86 | -$0.60 | -$0.26 |
| 11/12/2020 | Q3 | -- | -- | -$0.63 | -$0.67 | $0.04 |
| 08/12/2020 | Q2 | -- | -- | -$0.57 | -$0.62 | $0.05 |
| 05/13/2020 | Q1 | -- | -- | -$0.42 | -$0.61 | $0.19 |
| 03/16/2020 | Q4 | -- | -- | -$0.55 | -$0.58 | $0.03 |
| 11/12/2019 | Q3 | -- | -- | -$0.56 | -$0.43 | -$0.13 |
| 08/12/2019 | Q2 | -- | -- | -$0.26 | -$0.36 | $0.10 |
Akero Therapeutics Earnings Questions
-
How Much did Akero Therapeutics Generate in Revenue Last Quarter?
Akero Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Akero Therapeutics Beat Earnings Last Quarter?
Akero Therapeutics announced earnings per share of -$0.99 which represents a beat of analyst forecast a -$1.12 per share.
-
Is Akero Therapeutics Profitable?
Akero Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Akero Therapeutics EPS Next Year?
Akero Therapeutics's earnings are forecast to decrease from -$3.75 per share to -$3.95 per share next year representing a decrease of -12.69%.
-
When is Akero Therapeutics's Earnings Date?
Akero Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
